Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $54.3800 (1.42%) ($53.3500 - $54.3800) on Wed. Nov. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 80 | Latest Price | $54.3800(1.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 5.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(37%) IFRA(33%) IWO(32%) IWM(31%) IWN(29%) | Factors Impacting HALO price | HALO will decline at least -1.135% in a week (0% probabilities). VIXM(-11%) XBI(-7%) VXX(-6%) IGOV(-5%) GLD(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $53.4(1.84%) | 10 Day Moving Average | $53.54(1.57%) | 20 Day Moving Average | $50.64(7.39%) | To recent high | 0% | To recent low | 41.2% | Market Cap | $7.432b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |